Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMR001 Eye Drops for Moderate to Severe Dry Eye Disease
CTR20232068Phase 2Completed
- Sponsor
- Unnamed Biopharmaceutical Co., Ltd.
- Start
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of SMR001 in dry eye syndrome (DED), sponsored by Unnamed Biopharmaceutical Co., Ltd.. Started Jul 2023; status: completed.
02
Drugs
SMR001
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on CTR20232068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232068.